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Kidney fibrosis is a highly deleterious process and a final manifestation of chronic kidney
disease. Alpha-(α)-synuclein (SNCA) is an actin-binding neuronal protein with various
functions within the brain; however, its role in other tissues is unknown. Here, we describe
the expression of SNCA in renal epithelial cells and demonstrate its decrease in renal tubules
of murine and human fibrotic kidneys, as well as its downregulation in renal proximal tubular
epithelial cells (RPTECs) after TGF-β1 treatment. shRNA-mediated knockdown of SNCA in
RPTECs results in de novo expression of vimentin and α-SMA, while SNCA overexpression
represses TGF-β1-induced mesenchymal markers. Conditional gene silencing of SNCA in
RPTECs leads to an exacerbated tubulointerstitial fibrosis (TIF) in two unrelated in vivo
fibrotic models, which is associated with an increased activation of MAPK-p38 and PI3K-Akt
pathways. Our study provides an evidence that disruption of SNCA signaling in RPTECs
contributes to the pathogenesis of renal TIF by facilitating partial epithelial-to-mesenchymal
transition and extracellular matrix accumulation.
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F ibrotic disease is a dynamic and complex disorder char-acterized by an excessive accumulation and deposition ofextracellular matrix, subsequently leading to a formation of a
fibrous scar, destruction of an organ parenchyma and the loss of
organ function1,2. There is currently no treatment for this devas-
tating condition. However, elucidation of the intricate cellular and
molecular pathways underlying organ fibrosis could lead to the
development of effective therapeutic strategies to cure, or at least
delay, organ deterioration3. One of the tissues in which fibrosis is
the final pathway to organ failure is the kidney. The pathogenesis
of renal fibrosis engages multiple molecular pathways and various
renal and infiltrating cell types4. Among many cellular protago-
nists of the renal fibrotic process, one of the significant roles was
assigned to renal proximal tubular epithelial cells (RPTECs)3.
These cells are believed to be the major target for cellular injury
due to an exhaustive reabsorption of substantial volumes of fluid
and high enzymatic demands5. Being gifted by the unique
arrangements of the actin cytoskeleton6, RPTECs respond
to injury by de novo expression of mesenchymal markers and
reorganization of the actin cytoskeleton7,8, while still preserving
some of the epithelial characteristics2,9, a process recently rede-
fined as partial epithelial-to-mesenchymal transition (EMT)2,9.
Although still residing within the tubule, RPTECs through
paracrine signalling further promote inflammation, fibrosis, and
tissue damage3.
Alpha (α)–synuclein (SNCA) is a member of the synuclein
family of structurally related proteins, composed of α-, β- and γ-
synuclein, and synoretin10. SNCA is preferentially expressed in
areas of the adult central nervous system (CNS) that exhibit
synaptic plasticity11. In addition to its distribution within the
CNS, it has been reported that SNCA is also expressed in a variety
of non-neuronal cells and tissues12–18. A comparative study of
SNCA expression in the developing and adult human peripheral
tissues reveals that once the specific organ development is fin-
ished, the levels of SNCA in most of the peripheral tissues
decrease, except in the kidney, adrenal gland, and testis, implying
that SNCA could perform important physiological function in
these organs12.
Despite its implication in the pathogenesis of various synu-
cleinopathies19, the exact physiological function of SNCA still
remains unclear. Several studies demonstrated the existence of a
neuroprotective function of native SNCA against oxidative
stress20–22, neurodegeneration23,24 and apoptosis25,26. SNCA has
been proposed to play a major role in actin cytoskeletal organi-
zation and modulation of microfilament function27, which is
important for the normal functionality of neurons. Namely,
SNCA interacts with cytoskeletal components such as micro-
tubules28 and actin29 directly regulating function and dynamics of
actin cytoskeleton27. In rat hippocampus SNCA can activate the
N-methyl-D-aspartate receptor (NMDAR)30, a protein assembly
that intimately associates with actin cytoskeleton31. Interestingly,
previous results of our group demonstrated that activation of
NMDAR in RPTECs decreased EMT in vitro and significantly
attenuated renal fibrosis in vivo, pointing to an indispensable role
of this receptor in the preservation of normal epithelial phenotype
of RPTECs32,33.
In this report, we combine experimental studies using renal
tubular epithelial cells and conditional knockout mice with clin-
ical data from human renal tissues to assess and dissect the role of
renal tubular epithelial SNCA in kidney fibrosis. Here we show
that downregulation of SNCA enhances EMT in RPTECs in vitro
and that genetic ablation of epithelial SNCA results in an
aggravated fibrosis in two unrelated fibrosis models induced by
unilateral obstruction (UUO) and adenine rich diet. Our study
provides evidence for an important role of SNCA in preserving
the epithelial phenotype of RPTECs and in protecting kidney
parenchyma against injury. The results highlight the significance
of preserving the basal SNCA levels in the kidney as a therapeutic
strategy to attenuate the progression of kidney fibrosis.
Results
TGF-β1 treatment decreases SNCA expression in vitro. We first
evaluated the expression levels of different members of the
synuclein family in HK-2 cells in basal conditions. We found
significantly higher expression of SNCA in HK-2 compared with
the levels of β-synuclein (SNCB) and γ-synuclein (SNCG) (Sup-
plementary Fig. 1A, B). We next assessed the expression of SNCA
in HK-2 cells upon treatment with TGF-β1, an important med-
iator of fibrosis signaling in renal epithelial cells34,35. Alongside
changes in the epithelial phenotype, evident as a loss of cobble-
stoned morphology (Supplementary Fig. 2A, B), decrease of E-
cadherin (Fig. 1b, c) and an increase of α-SMA and vimentin
(Fig. 1b and e–f), TGF-β1 induced a significant decrease of SNCA
mRNA (Fig. 1a; 48 and 72 h) and protein expression (Fig. 1b and
D; 72 h) in a dose- (Fig. 1a, d) and time-dependent manner
(Fig. 1a). The immunofluorescence showed a visible loss of SNCA
protein in the cytoplasm and nuclei of HK-2 cells treated with
TGF-β1 (72 h, Fig. 1g). These results suggest a dysregulation of
endogenous SNCA after TGF-β1 treatment in HK-2 and raise
the possibility of its potential role in maintaining the epithelial
phenotype of renal proximal tubular cells in vitro.
Knockdown of SNCA influences RPTEC phenotype. To con-
firm the possible role of basal SNCA levels in preserving the
epithelial phenotype in vitro, we first disrupted the expression of
SNCA by short hairpin RNA (shRNA). HK-2 were infected with
FSVsi-SNCA (shSNCA) or FSVsi (VC, control vector), and
subsequently incubated either with 2 ng/ml of TGF-β1 or were
left untreated for 72 h. HK-2 infected with FSVsi-SNCA showed
an evident decrease of SNCA expression compared with the
control (Fig. 2a, b), while mRNA and protein levels of SNCB and
SNCG did not change between VC and shSNCA (Supplementary
Fig. 1C–E). Interestingly, downregulation of SNCA in HK-2
(shSNCA) induced changes in the epithelial phenotype, evident as
a modest decrease of E-cadherin (Fig. 2a, c) and a marked
increase of α-SMA (Fig. 2a, e) and vimentin (Fig. 2a, d) compared
with the control (VC). Additionally, knockdown of SNCA
induced visible changes in actin organization seen as an increase
in Phalloidin fluorescence (Fig. 2k). Although TGF-β1 led to a
higher expression of mesenchymal markers (Fig. 2a and d–e) and
more pronounced reorganization of actin cytoskeleton (Fig. 2k)
in cells infected with control vector, this was not the case in
shSNCA cells, for which the levels of α-SMA and vimentin
expression were not further increased by TGF-β1 treatment and
were similar to those of VC+ TGF-β1 condition (Fig. 2d, e).
These results reveal an important role of basal SNCA levels in
maintaining the epithelial phenotype of renal tubular cells.
SNCA overexpression inhibits TGF-β1-induced α-SMA and
vimentin in vitro. Next, we stably overexpressed SNCA in HK-2,
after which the cells were incubated with 2 ng/ml of TGF-β1 or
were left untreated for 72 h. Figure 2f and g shows an evident
increase of SNCA expression in HK-2 infected with SIN-PGK-
hsynuclein-WHV (SNCA Ox) compared with control vector
(VC), confirming the successful overexpression of the target
protein. TGF-β1 treatment induced a marked increase of α-SMA
and vimentin after 72 h of exposure (Fig. 2f, i–j), which was
significantly blunted in HK-2 cells overexpressing SNCA (two-
way ANOVA: p < 0.05). Overexpression of SNCA in HK-2 failed
to reestablish the normal expression of E-cadherin in cells treated
with TGF-β1 (Fig. 2f, h).
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SNCA modulates the activation of ERK1/2, Akt and p38
in vitro. To study the potential cellular signaling pathway, we
examined activities of MAPK and PI3K-Akt pathways, which are
known to have critical role in the EMT of renal tubular cells and
the progression of kidney fibrosis32,36. Knockdown of SNCA in
HK-2 (shSNCA) induced an increase of pERK1/2, pAkt and p-
p38 compared with control cells (VC), with pAkt and p-p38
reaching statistical significance (Fig. 3a, b). Although TGF-β1
treatment resulted in higher levels of pERK1/2, pAkt and p-p38 in
cells infected with control vector, this was not the case in shSNCA
cells, for which the levels of phosphorylated proteins were not
further increased by the treatment (Fig. 3a, b). Overexpression of
SNCA did not significantly affect the activity of pERK1/2, pAkt
and p-p38 at basal state, nevertheless there was a tendency of
decreasing the levels of p-p38 and pAkt in TGF-β1 treated cells
(Supplementary Fig. 3A). To elucidate the possible mechanism
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Fig. 1 TGF-β1 leads to a decrease of SNCA expression in HK-2 in vitro. Human renal proximal tubular epithelial (HK-2) cells were incubated in serum-free
medium (control) or TGF-β1 for 24 h (a), 48 h (a) and 72 hours (a, b–f). a Total mRNA was extracted from HK-2 cells and mRNA levels of SNCA were
determined by quantitative real-time PCR and normalized to GAPDH. Data are presented as mean ± SEM of at least n= 3 independent experiments. b Cell
lysates were immunoblotted with antibodies against E-cadherin, SNCA, vimentin and α-SMA. The same samples were reprobed with antibodies against
tubulin to ensure equal loading. Representative Western blots (b) and quantitative densitometric analysis (c–f) show decrease of E-cadherin and SNCA
expression and an increase of vimentin and α-SMA expression in HK-2 cells treated with TGF-β1 for 72 h. Data are presented as mean ± SEM of at least
n= 2 independent experiments. g Immunofluorescence staining for the distribution of SNCA in HK-2 cells after incubation with TGF-β1 for 72 h. Scale bar
represents 20 µm. *p < 0.05, **p < 0.01, ***p < 0.001. The p-value by one-way ANOVA. Source data are provided as a Source Data file.
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that stands behind the enhanced activity of MAPK pathway upon
knockdown of SNCA, we first analyzed the expression of pMKK3
and pMKK6, two closely related dual-specificity protein kinases
known to phosphorylate p38 MAP kinase. Knockdown of SNCA
in HK-2 cells did not have any effect on the phosphorylation
of MKK3/6, while the levels of p-p38 stayed increased (Supple-
mentary Fig. 3B). To confirm that effects of SNCA knockdown on
p38 MAPK phosphorylation are not due to MKK3/6 activity,
we co-transfected cells with MKK6E and SNCA-flag plasmids.
Co-transfection experiments showed that SNCA managed to
decrease the levels of phosphorylated p38 in cells with con-
stitutive activation of MKK6 kinase (Supplementary Fig. 3 C, D),
confirming that SNCA does not actuate through MKK3/6 kinase,
but downstream of it. Our next step was to investigate the pos-
sible interaction between SNCA and p38 MAPK. As shown
in Fig. 3f, p38 MAPK colocalized with SNCA in HK-2 cells in
basal conditions. Moreover, co-immunoprecipitation experiments
using cell lysates from HEK293T cells co-transfected with SNCA-
flag and p38-HA confirmed the interaction of SNCA with p38
MAPK (Fig. 3g).
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Fig. 2 SNCA modulates the epithelial phenotype in vitro. HK-2 cells (VC, shSNCA or SNCA Ox) were incubated with serum-free medium or treated with
TGF-β1 (2 ng/ml) for 72 h. a, f Cell lysates were immunoblotted with antibodies against E-cadherin, SNCA, vimentin, and α-SMA. The same samples were
reprobed with antibodies against tubulin to ensure equal loading. Representative Western blots (a, f) and quantitative densitometric analysis (b–j) show
expression of SNCA, E-cadherin, α-SMA, and vimentin in VC and shSNCA cells (a, b–e) or VC and SNCA Ox cells (f, g–j) treated with TGF-β1 for 72 h.
Data are presented as mean ± SEM of at least n= 3 independent experiments. k F-actin staining for the detection of actin filaments in HK-2 cells. Cells
were incubated with serum-free medium or treated with TGF-β1 (2 ng/ml) for 24 h. F-actin was labeled with Phalloidin Alexa Fluor 568 (red). Nuclei were
counterstained with Hoechst (blue). Scale bar represents 20 µm. *p < 0.05, **p < 0.01, ***p < 0.001. The p-value by two-way ANOVA. VC—control vector;
shSNCA—cells with SNCA downregulation; SNCA Ox—cells overexpressing SNCA. Source data are provided as a Source Data file.
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Next, we sought to investigate the mechanism that stands
behind the TGF-β1-induced decrease in SNCA expression.
Treatment with p38 kinase inhibitor (SB203580) significantly
attenuated TGF-β1-mediated decrease in SNCA expression (Fig. 3c,
d). PI3K kinase inhibitor (LY294002) showed a tendency to
decrease the TGF-β1-induced downregulation of SNCA (Fig. 3c,
d), while MAPK-ERK1/2 kinase inhibitor (U0126) did not have
any affect (Fig. 3c, d). These results suggest that MAPK-p38
signaling is one of the pathways implicated in the TGF-β1-
mediated regulation of SNCA expression in HK-2 cells.
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Next, we assessed the signaling pathway responsible for an
increase in vimentin expression induced by a downregulation of
SNCA in HK-2 cells. Interestingly, an increase of vimentin
expression in shSNCA cells was blunted after treatment with
PI3K kinase inhibitor (LY294002), while MAPK/ERK1/2 kinase
inhibitor and p38 kinase inhibitor did not decrease its expression
(Fig. 3e). These results point toward a role of PI3K-Akt pathway
in the SNCA-mediated regulation of vimentin expression in HK-
2 cells.
SNCA expression decreases in obstructed mouse kidneys. To
investigate the potential role of SNCA in renal fibrosis, we sub-
jected C57BL/6J wild-type mice to unilateral ureteral obstruction
(UUO), a well-studied model of renal tubulointerstitial fibrosis
and disease progression37. As expected, UUO led to significant
fibrotic changes in the obstructed kidneys at 5 and 15 days after
the operation (Fig. 4a, b and d–g). Remarkably, UUO induced a
marked decrease of SNCA mRNA in the obstructed kidneys
starting from day 5 post-UUO (Fig. 4c), subsequently leading to a
further decrease with the progression of the disease (day 15 post-
UUO, Fig. 4c). Immunohistochemistry study showed that SNCA
protein was mainly expressed in the cytoplasm and nuclei of the
healthy renal tubular epithelium (Fig. 4g and Supplementary
Fig. 4, A, B). Collecting ducts stained positively, as did glomeruli
(Supplementary Fig. 4 C, D). After challenge with UUO, mice
exhibited an evident decrease of SNCA expression in dilated renal
tubules as early as 5 days after surgery (Fig. 4g). Subsequently,
levels of SNCA further decreased and almost disappeared in some
tubules by day 15 after UUO (Fig. 4g). Furthermore, using triple
immunofluorescence staining, we managed to identify SNCA
negative tubular cells in areas of fibrosis showing de novo
expression of vimentin, while still preserving the expression of
epithelial marker E-cadherin (Supplementary Fig. 5A–D). Our
results in vivo confirm a newly established concept of partial
EMT program and its contribution to the development of renal
fibrosis.
SNCA expression decreases in human kidneys with fibrosis.
Next, we assessed the expression of SNCA in kidneys of patients
with chronic kidney disease. As a control we used the healthy area
of renal tissue from patients who underwent nephrectomy due to
malignancies or hydronephrosis. Paraffin-embedded renal tissue
sections were stained for SNCA, α-SMA, FSP1, and Sirius Red.
Similar to mouse kidney, SNCA was predominantly localized in
the cytoplasm and nuclei of the healthy renal tubular epithelium
(granular staining) (Fig. 5a). As expected, chronic kidney disease
(CKD) samples showed significant levels of interstitial fibrosis
(Fig. 5a, c–d) (see patient’s characteristics in Supplementary
Table 1). We found that, in patient samples, SNCA expression
significantly decreased in the cytoplasm and nuclei of the dilated
renal tubules (Fig. 5a, b) Linear regression analysis showed an
inverse correlation between the percentage of SNCA positive
tubules and the degree of α-SMA staining, as well as the extent of
renal interstitial fibrosis measured by Sirius red staining (Fig. 5e
and f, respectively). We did not detect any correlation between
the tubular SNCA expression and the glomerular filtration rate
(eGFR) (R2= 0.0204; p= 0.3862). Additionally, we were able to
find dilated tubules in the areas of fibrosis with tubular cells
showing absence of SNCA expression while presenting de novo
expression of mesenchymal marker vimentin (Supplementary
Fig. 6).
RPTEC-specific SNCA gene deletion in mice. To investigate the
physiological function of proximal tubule SNCA and its role in the
pathogenesis of renal fibrosis, we generated mice with specific
deletion of SNCA from renal proximal tubule by crossing homo-
zygous SNCA-floxed mice (SNCAflox) with PEPCKCre+ transgenic
mice. PCR analysis of tail DNA confirmed the genotypes of prox-
imal tubule specific SNCA null mice (PEPCKCre+-SNCAfl/fl) and
the control wild-type mice (PEPCKCre+-SNCAwt/wt) (Supplemen-
tary Fig. 7 A, B). Bands of WT or floxed SNCA alleles were observed
at ~390 bp and 440 bp, respectively (Supplementary Fig. 7A), while
the expression of Cre transgene was visualized by a 465 bp PCR
product (Supplementary Fig. 7B). PEPCKCre+-SNCAfl/fl (mutant)
mice were born at the expected Mendelian ratio and did not show
abnormalities at birth, neither at the age of 8–10 weeks when the
experiments started.
To affirm specific Cre recombinase activity, we crossed
PEPCKCre mice with reporter mT/mG [B6.129(Cg)-Gt(ROSA)
26Sortm4(ACTB-tdTomato-EGFP)Luo/J] mice. Supplementary Figure 7C
demonstrates kidney EGFP reporter immunofluorescence expres-
sion representative of Cre recombinase activity in B6.129(Cg)-Gt
(ROSA)26Sortm4(ACTB-tdTomato-EGFP)Luo/J mouse crossed with
PEPCKCre+ mouse. The specificity of SNCA deletion in renal
proximal tubular epithelial cells (RPTEC-SNCA deletion) was
assessed by double immunofluorescence staining of SNCA with
lotus tetragonolobus agglutinin (LTA), a specific renal proximal
tubule marker38,39, in kidneys of PEPCKCre+-SNCAwt/wt and
PEPCKCre+-SNCAfl/fl mice at baseline (Fig. 6a, b). While the
expression of LTA on the brush border of proximal tubules stayed
unchanged in both groups of mice, SNCA expression on RPTECs
of PEPCKCre+-SNCAfl/fl mice was visibly reduced, and nearly
absent in certain areas (Fig. 6a). The SNCA protein expression
pattern remained normal in the distal tubular cells (Fig. 6a).
Likewise, the mRNA expression of SNCA in the whole kidney was
significantly reduced (t-test: p < 0.05, Fig. 6c). These results
affirmed SNCA deletion from RPTECs of the mutant mice.
RPTEC-SNCA deletion accelerates the profibrotic gene expres-
sion after UUO. Next, we subjected PEPCKCre+-SNCAwt/wt and
PEPCKCre+-SNCAfl/fl mice to UUO challenge to determine if
SNCA deficiency from RPTECs may render the obstructed kid-
neys of mutant mice more susceptible to renal fibrosis. mRNA
expression of type I collagen, fibronectin, α-SMA and vimentin
increased in obstructed kidneys of both PEPCKCre+-SNCAwt/wt
and PEPCKCre+-SNCAfl/fl mice as early as 5 days after UUO, but
to a significantly higher extent in PEPCKCre+-SNCAfl/fl mice
(Fig. 6d; two-way ANOVA: p < 0.001, p < 0.01, p < 0.05, respec-
tively). Of note, expression of α-SMA, vimentin, type I collagen
and TGF-β1 mRNA showed a modest increase in the contralateral
kidneys of PEPCKCre+-SNCAfl/fl mice 5 days after UUO, com-
pared with control littermates (Fig. 6d), reaching statistical sig-
nificance 15 days after UUO (Fig. 6e). As the disease progressed,
obstructed kidneys of mutant mice still maintained the higher
expression levels of profibrotic genes compared with control lit-
termates, with collagen I mRNA reaching statistical significance
(Fig. 6e). Of note, levels of cadherin-16 mRNA, a kidney-specific
cadherin expressed in renal epithelial cells9, were significantly
lower in obstructed kidneys of PEPCKCre+-SNCAfl/fl animals
15 days after UUO, compared with PEPCKCre+-SNCAwt/wt mice
(Fig. 6e).
RPTEC-SNCA deletion increases interstitial matrix deposition
and myofibroblast activation after UUO. UUO led to a marked
increase in collagen accumulation and deposition in wild-type
kidneys at both time points (Fig. 7k, l, o, p), while disruption of
SNCA gene from RPTECs further enhanced the collagen
deposition seen as a greater red staining area in kidneys of
PEPCKCre+-SNCAfl/fl mice at day 15 after UUO (Fig. 7k, l, o, p).
Immunohistochemistry for detection of collagen type I in mouse
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kidneys corroborated the results obtained after Sirius red staining
(Fig. 7m–p). Consistently, the collagen I protein levels were sig-
nificantly higher in PEPCKCre+-SNCAfl/fl-obstructed kidneys
than in wild-type obstructed kidneys at day 15 of UUO (Fig. 7b
and j; two-way ANOVA: p < 0.05). Fibronectin protein levels
showed a significant increase in PEPCKCre+-SNCAfl/fl-obstructed
kidneys at day 5 after UUO, compared with wild-type littermates
(Fig. 7a, e). The protein expression of α-SMA and vimentin,
molecular markers of mesenchymal phenotype, was notably
induced by UUO in kidneys of both PEPCKCre+-SNCAwt/wt and
PEPCKCre+-SNCAfl/fl mice (Fig. 7a–d, g–h), however a sig-
nificantly stronger expression of both myofibroblast markers was
observed in the kidneys of mutant mice at day 5 (α-SMA,
vimentin) and day 15 (α-SMA) of UUO (Fig. 7a–d, g–H). Con-
sistently, immunohistochemistry showed more prominent stain-
ing for α-SMA and fibroblast specific protein (FSP1) in the
obstructed kidneys of mutant mice compared with their control
littermates (Fig. 7o, p).
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RPTEC-SNCA deletion aggravates adenine-induced renal
fibrosis. To validate our findings, we extended our studies to an
additional model of renal fibrosis, adenine-induced tubulointer-
stitial nephropathy in mice. Of note, four weeks of adenine diet
feeding led to a development of tubular interstitial fibrosis and the
significant decline of SNCA mRNA in the kidneys of WT mice,
compared with wild-type littermates fed a normal diet (Fig. 8k).
Furthermore, adenine diet induced a significant increase of blood
urea nitrogen (BUN) in the serum of both PEPCKCre+-SNCAwt/wt
and PEPCKCre+-SNCAfl/fl mice, compared with their counter-
parts fed a regular diet (Supplementary Fig. 8). As expected,
adenine rich diet induced an increase of profibrotic markers such
as type I collagen, fibronectin, α-SMA, vimentin and TGF-β1
mRNA and a decrease of cadherin-16 mRNA in kidneys of
PEPCKCre+-SNCAwt/wt mice compared with wild-type littermates
fed a normal diet (Fig. 8a–f). Notably, levels of tested profibrotic
genes were significantly higher in PEPCKCre+-SNCAfl/fl mice fed
an adenine diet (Fig. 8a–f, two-way ANOVA: p < 0.01 Coll I,
α-SMA, FN; p < 0.05, vimentin), except for TGF-β1, which did not
reach statistical significance (Fig. 8e). Adenine rich diet led to a
marked increase of collagen accumulation and deposition in wild-
type kidneys (Fig. 8j, n), while disruption of SNCA gene from
RPTECs further enhanced the collagen deposition seen as a
greater red staining area in kidneys of PEPCKCre+-SNCAfl/fl mice
fed an adenine rich diet (Fig. 8j, n). Immunohistochemistry for
detection of collagen type I in mouse kidneys corroborated the
results obtained after Sirius red staining (Fig. 8l, n, two-way
ANOVA: p < 0.01). The protein expression of α-SMA, vimentin
and collagen I was notably induced by adenine rich diet in kidneys
of both PEPCKCre+-SNCAwt/wt and PEPCKCre+-SNCAfl/fl mice
(Fig. 8g–i, m), however a significantly stronger expression of all
tested markers was observed in the kidneys of mutant mice fed
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an adenine diet (Fig. 8g–i, m; two-way ANOVA: p < 0.01
α-SMA; p < 0.05 Coll I). Consistently, immunohistochemistry
showed more prominent staining for α-SMA and FSP1 in the
kidneys of mutant mice fed an adenine rich diet compared with
PEPCKCre+-SNCAwt/wt littermates fed the same diet (Fig. 8n).
Furthermore, triple immunofluorescence staining of kidney
sections from wild-type mice fed an adenine rich diet revealed
that various tubular cells in the areas of fibrosis showing
decreased or even lost SNCA expression begin to express
mesenchymal marker vimentin, while still preserving the
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expression of epithelial marker E-cadherin (Supplementary
Fig. 9a–d).
SNCA modulates the activation of ERK1/2, Akt, and p38 after
UUO. To assess the involvement of MAPK and PI3K-Akt path-
ways in accelerated fibrotic response in PEPCKCre+-SNCAfl/fl
mice upon UUO in vivo, we analyzed the expression levels of
pERK1/2, pAkt, and p-p38 in the kidneys of both PEPCKCre+
-SNCAwt/wt and PEPCKCre+-SNCAfl/fl mice. We found a marked
increase of pERK1/2, pAkt, and p-p38 in obstructed kidneys
of PEPCKCre+-SNCAfl/fl animals as early as 5 days after
UUO, compared with PEPCKCre+-SNCAwt/wt mice, with p-p38
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and pAkt reaching statistical significance (Fig. 9a, c, d; two-way
ANOVA: p < 0.05 pAkt). Furthermore, using double immuno-
fluorescence staining, we managed to identify SNCA negative
tubular cells in the areas of fibrosis showing increased expression
of p-p38, while healthy SNCA positive tubules showed no staining
for phosphorylated p38 (Supplementary Fig. 10a–c).
Discussion
In this study, we describe the presence of SNCA in RPTECs and
establish the functional significance of endogenous SNCA
expression in these cells, proposing a role for SNCA in protecting
kidney against fibrotic injury.
Renal fibrosis is a final manifestation of chronic kidney disease
where TGF-β1 is considered a key mediator of fibrotic signaling
in renal epithelial cells34–36. First, we sought to investigate the
relationship between SNCA and TGF-β1 in vitro. Treatment with
TGF-β1 led to marked changes in epithelial phenotype of HK-2
cells, which was in accordance with previously published
results32. Furthermore, TGF-β1 led to a significant decrease of
SNCA mRNA and protein expression in a dose- and time-
dependent manner, suggesting a possible involvement of this
protein in EMT of tubular epithelial cells. To corroborate the
potential role of SNCA in the maintenance of the epithelial
phenotype of renal tubular cells in vitro, the expression of SNCA
in HK-2 was disrupted by shRNA delivery. Thus, knockdown of
SNCA in HK-2 caused a modest decrease of E-cadherin and a
marked increase of the expression of mesenchymal markers, α-
SMA and vimentin. The already increased expression levels of
mesenchymal markers in shSNCA cells did not further increase
with TGF-β1 treatment, suggesting an overriding effect of SNCA,
at least in vitro. On the other hand, overexpression of SNCA in
HK-2 cells managed to blunt the TGF-β1-induced expression of
major cytoskeletal components of mesenchymal cells40, α-SMA
and vimentin. The role of SNCA in regulating actin cytoskeletal
organization has been previously reported in neurons27–29,
emphasizing its function as a major modulator of microfilament
function and cytoskeletal dynamics27–29. Thus, Sousa et al.27
demonstrated that SNCA binds actin, slows down its poly-
merization and accelerates its depolymerization. Furthermore,
Bellani et al.29 indicated that SNCA was able to reduce the pool of
polymerized actin available in the cells by sequestering actin
monomers. Results of our study show that knockdown of SNCA
in HK-2 cells stimulated reorganization of the actin cytoskeleton
seen as a stress fiber formation. In our study, we did not detect an
increase of other synuclein’s oligomers in HK-2 cells carrying
shRNA for SNCA, but we still cannot absolutely exclude possible
toxicity of these structures even in picomolar concentrations.
Further investigation is needed to elucidate the possible forma-
tion and functionality of oligomeric SNCB and SNCG in the
settings of SNCA deficiency in HK-2 cells.
Once established that the expression of SNCA was decreased in
TGF-β1-treated cultures, we assessed the expression of SNCA in a
mouse model of renal fibrosis, as well as in patients with kidney
disease. Our results demonstrate that SNCA was significantly
downregulated in dilated renal tubules of both human and mouse
kidneys affected by fibrosis, compared with normal human kid-
ney tissue or contralateral non-obstructed mouse kidneys in the
UUO model, respectively. These findings suggest to a dysregu-
lation of endogenous SNCA levels in kidney fibrosis and raise the
possibility that SNCA could play a role in fibrosis development.
In our human study, we detected an inverse correlation between
the percentage of SNCA positive tubules and the degree of α-
SMA and Sirius red staining in fibrotic kidneys; however, there
was no correlation between the tubular SNCA expression and the
eGFR. The lack of association between the loss of tubular SNCA
expression and declining renal function presumably reflects the
rather eclectic group of CKD patients analyzed in our study, with
only small number of patients with glomerulonephritis.
To circumvent the systemic effect of global SNCA depletion
using a conventional SNCA knockout mouse model, and to
directly assess the potential role of renal proximal tubule SNCA
in kidney fibrosis, we used conditional gene targeting and selec-
tively deleted SNCA expression in mouse RPTECs. We found that
PEPCKCre+-SNCAfl/fl mice developed more severe tubulointer-
stitial injury and fibrosis after UUO, compared with control lit-
termates. Thus, normal endogenous expression of SNCA in
RPTECs significantly attenuated the detrimental effects of
obstructive nephropathy. The protective effect of SNCA seems to
involve a reduction of profibrotic gene expression, as well as
decreased myofibroblast activation and interstitial matrix
deposition. Myofibroblasts are considered the principal mediators
of renal fibrosis responsible for the interstitial matrix accumula-
tion and deposition41,42. Indeed, we observed significantly higher
mRNA and protein expression of α-SMA and vimentin in the
obstructed kidneys of PEPCKCre+-SNCAfl/fl mice. Furthermore,
SNCA expression also reduced ECM production in obstructed
kidneys. Namely, PEPCKCre+-SNCAfl/fl mice showed sig-
nificantly higher levels of fibronectin mRNA expression as well as
collagen I mRNA and protein levels, which led to an aggravation
of the fibrotic phenotype after UUO. Importantly, our in vivo
results were confirmed in a second model of renal fibrosis,
adenine-induced tubulointerstitial nephropathy in mice. Results
obtained using two mechanistically distinct mouse models of
renal fibrosis support the finding that SNCA from RPTECs has a
role in protecting kidney parenchyma against injury. Several
studies demonstrated a protective effect of SNCA against different
types of injuries in the brain20,23,25,26,43, including the CSPα
depletion-induced neurodegeneration that led to gliosis23, a form
of fibrosis of the CNS44.
The MAPK & PI3K pathways have been reported to play a vital
role in the EMT of different epithelial cells in vitro32,45–47, as well as
the progression of renal fibrosis in vivo36. In the present study,
SNCA knockdown led to a significant increase of pAkt and p-p38
in HK-2 cells. The already elevated expression levels of pAkt and
Fig. 7 RPTEC-SNCA deletion increases interstitial matrix deposition and myofibroblast activation after UUO. PEPCKCre+ SNCAwt/wt and PEPCKCre+
SNCAfl/fl mice were subjected to UUO and sacrificed 5 and 15 days after obstruction. a, b Whole kidney lysates from contralateral non-obstructed (CTL)
and obstructed (UUO) kidneys were processed for protein analysis at days 5 and 15 after UUO and were immunoblotted with antibodies against α-SMA,
vimentin, collagen I, fibronectin and GAPDH. a, b Representative Western blot analysis of α-SMA, vimentin, collagen, and fibronectin in the kidneys of
PEPCKCre+ SNCAwt/wt and PEPCKCre+ SNCAfl/fl mice subjected to UUO. c–j Quantitative analysis by densitometry. Data were normalized to GAPDH and
presented as mean ± SEM (n= 7 mice/group for UUO5; n= 7–9 mice/group for UUO15) (fold change over CTL PEPCKCre+ SNCAwt/wt). Quantification of
collagen deposition in kidneys of PEPCKCre+ SNCAwt/wt and PEPCKCre+ SNCAfl/fl mice after Sirius red staining (k, l) and immunohistochemistry for
collagen I (m, n) was expressed as a positive stained area vs. total analyzed area. Data are presented as mean ± SEM (n= 5–9 mice/group (UUO5),
n= 7–10 mice/group (UUO15), Sirius red; n= 6–10 mice/group, collagen I). *p < 0.05, **p < 0.01, ***p < 0.001. The p-value by two-way ANOVA.
o, p Representative images of Sirius red staining and immunohistochemistry for α-SMA, FSP1 and collagen I in mouse kidneys 5 (o) and 15 (p) days after
UUO. Scale bar represents 50 µm (Collagen I, Sirius red) or 20 µm (α-SMA, FSP1). Source data are provided as a Source Data file.
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Fig. 8 RPTEC-SNCA deletion aggravates adenine-induced renal fibrosis. a–f, k Total mRNA was extracted from kidneys of PEPCKCre+ SNCAwt/wt and
PEPCKCre+ SNCAfl/fl mice fed a regular or adenine rich diet for 4 weeks. mRNA levels of collagen I, fibronectin, α-SMA, vimentin, TGF-β1, cadherin-16 and
SNCA were determined by quantitative real-time PCR and normalized to TBP. m Whole kidney lysates were processed for protein analysis and were
immunoblotted with antibodies against α-SMA, vimentin, collagen I and GAPDH. m Representative Western blot analysis and g–i quantitative analysis by
densitometry. j, l Quantification of collagen deposition in kidneys of PEPCKCre+ SNCAwt/wt and PEPCKCre+ SNCAfl/fl mice after Sirius red staining (j) and
immunohistochemistry for collagen I (l) was expressed as a positive stained area vs. total analyzed area. Data are presented as mean ± SEM (n= 5–7
mice/group). *p < 0.05, **p < 0.01, ***p < 0.001. The p-value by two-way ANOVA. n Representative images of Sirius red staining and
immunohistochemistry for α-SMA, FSP1 and collagen I in mouse kidneys. Scale bar represents 50 µm. Source data are provided as a Source Data file.
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p-p38 in shSNCA cells did not further increase with TGF-β1
treatment, implying to an outweighing effect of SNCA knockdown
in vitro. On the other hand, SNCA overexpression did not show
marked effects on the activity of Akt and p38 in basal state,
nonetheless there was a tendency toward decreasing the levels of the
two phosphorylated proteins after TGF-β1 treatment. Furthermore,
our results in vitro were confirmed in vivo. Namely, PEPCKCre+
-SNCAfl/fl mice showed significantly higher levels of p-p38
and pAkt in obstructed kidneys, compared with PEPCKCre+
-SNCAwt/wt littermates. Wishing to further study the mechanism
governing this activation of p38 and Akt by SNCA knockdown we
found that SNCA associates and binds to p38 MAPK, while over-
expression of SNCA decreases phosphorylation of p38 in cells with
constitutive activation of MKK6 kinase. Based on the fact that
SNCA binds to p38 MAPK, it is more likely that the loss of SNCA
affects phosphorylation of this signaling molecule. The binding of
SNCA to p38 could explain not only the activation of p38 upon
SNCA downregulation, but also the subsequent activation of Akt in
HK-2 cells. Namely, it has been shown that p38 pathway can
influence Akt signaling, placing Akt kinase downstream of p38
MAPK48,49. Cabane et al.48 demonstrated that stimulation of p38
resulted in a simultaneous activation of Akt pathway, while the
inhibition of p38 led to a reduction of pAkt levels. Interestingly,
neither inhibition nor activation of Akt had any effect on p-p38
levels in C2C12 cells48. McGuire et al.49 confirmed the results from
previous group demonstrating the existence of a cross talk between
the p38α-MK2/3 and Akt pathways in macrophages and described
a role for p38α-MK2/3 in regulating TLR-induced Akt activation in
macrophages. The results obtained here depict the role for SNCA in
regulating MAPK-p38 and PI3K-Akt pathways and are in line with
previously published data in CNS21,22,50. Namely, Iwata et al.50
demonstrated that SNCA affects the phosphorylation of MAPKs
and that binding of SNCA to p38 MAPK regulates MAPK pathway
by reducing the amount of available p38 to be phosphorylated.
Furthermore, Musgrove et al.21 showed that SNCA, through inhi-
bition of the MAPK signaling pathway, prevented cytochrome c
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and sacrificed 5 days after obstruction. Whole kidney lysates from contralateral non-obstructed (CTL) and obstructed (UUO) kidneys were processed for
protein analysis and were immunoblotted with antibodies against pERK1/2, pAkt, p-p38, total ERK1/2 and GAPDH. a Representative Western blots and
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release and apoptosis. Our focus on MAPK-p38 and PI3K-Akt
pathways in this study does not exclude the possibility of other
signaling cascades mediating the effects of loss of SNCA in RPTECs.
Namely, SNCA has an important role in mitochondrial homeostasis
and the alteration of this protein could lead to bioenergetics defects
and neuronal impairments51. Considering the fact that RPTECs
represent an important energy-demanding cell type that contains
more mitochondria than any other structure in the kidney, the
potential role of SNCA in the mitochondrial bioenergetics of
RPTECs could not be neglected. Further investigation in this
direction is needed as it may provide more insights into the com-
plex roles of SNCA in peripheral tissues such as the kidney.
To investigate the molecular mechanism underlying TGF-β1-
induced decrease in SNCA expression in vitro, we performed
MAPK and PI3K inhibitor study. We found that SB203580
significantly attenuated TGF-β1-mediated decrease in SNCA
expression, while LY294002 managed to partially blunt it. It thus
seems like that the decrease in SNCA expression induced by
TGF-β1 is mediated by MAPK-p38. Similar MAPK-p38 and
PI3K-dependent regulation of SNCA expression was reported by
Gomez-Santos et al.52 and Clough et al.53. In their reports, the
increase in SNCA expression caused by dopamine52 or NGF and
bFGF53 was attenuated by SB20358052 or LY29400253, respec-
tively. The present study reports that TGF-β1 decreases SNCA
expression via MAPK-p38 activation.
In conclusion, our study provides evidence for an important
role of SNCA in the maintenance of the epithelial phenotype of
RPTECs and in protecting kidney parenchyma against injury.
Besides identifying the functional relevance for endogenous
SNCA expression in the RPTECs and the kidney, our work also
emphasizes the importance of preserving the basal SNCA levels in
the kidney as a therapeutic strategy to attenuate the progression
of kidney fibrosis.
Methods
Cell culture and treatments. HK-2 cells (human renal proximal tubular epithelial
cells)54 (ATCC® CRL-2190™) were maintained in DMEM/F12 media (Gibco™)
supplemented with 2% FBS, Hepes buffer, insulin, transferrin, sodium selenite,
glucose, dexamethasone, EGF, penicillin, and streptomycin (Sigma Aldrich). Fresh
growth medium was changed every 2–3 days. Before treatments, cells were growth
arrested in serum-free medium and incubated separately with serum-free medium
(control), transforming growth factor-β1 (TGF-β1: 1, 2, 4 ng/ml; R&D Systems,
Minneapolis, MN) and/or U0126 (10 µM/L; #662005, Calbiochem), SB203580
(20 µM/L; #559389, Calbiochem), LY294002 (10 µM/L; #440202, Calbiochem) for
different periods of time. Cells were maintained according to the described pro-
tocol, unless otherwise indicated.
Lentiviral production and infection of HK-2 cells. The shRNA vector was con-
structed by annealing complementary 60-mer oligonucleotides containing the 21-
nucleotide target sequence in both the sense and antisense orientation separated by
a 9-nt spacer. The 21-mer sequence to α-SYN (SNCA) was TGA-
CAATGAGGCTTATGAAAT and is predicted to be specific only for α-SYN as
determined by BLAST database searches. Oligonucleotides to produce shRNA were
annealed in buffer (150 mM NaCl; 50 mM Tris, pH 7.6) and cloned into the AgeI-
BamHI site of lentiviral vector for RNA interference-mediated gene silencing under
the control of U6 promoter for the expression of short hairpin shRNAs and the
Venus variant of GFP under the control of SV40 promoter for monitoring
transduction efficiency. The pSIN-pgk-human Synuclein WT-WPRE plasmid
(SIN-PGK-hsynuclein-WHV) for the production of lentiviral particles to express
human SNCA was a kind gift from Dr. Bernard Schneider (Swiss Federal Institute
of Technology Lausanne, Switzerland). To produce lentiviral particles, 293T cells
were co-transfected by the polyethylenimine method with virion packaging ele-
ments (VSV-G and Δ8.9) and the shRNA producing vector. 293 T cells were
allowed to produce lentiviral particles for 3 days in DMEM supplemented with 10%
FBS, sodium pyruvate, nonessential amino acids, penicillin, and streptomycin.
Culture medium was collected and centrifuged at 3000 rpm for 10 minutes.
Supernatant was collected and filtered using Sartorius filters at 4000 rpm for 1 h,
4 °C. Filtered supernatant was added to the growing culture of HK-2 cells and
incubated overnight. Next morning, fresh medium was replaced, and the cells were
grown for an additional 3–4 days to allow endogenous gene knockdown. Western
blot and real-time PCR were performed to check for α-SYN gene knockdown and/
or overexpression.
RNA purification and quantitative real-time PCR. Total RNA was extracted from
cultured cells or from whole kidney tissue using TRIzol reagent (Sigma, Madrid,
Spain), and reverse transcription was performed with First Strand cDNA Synthesis
Kit (AMV) (Roche) according to manufacturer’s instructions. Real-time PCR with
gene-specific TaqMan probes was performed with a CFX Real-Time PCR detection
system (Bio-Rad Laboratories, Madrid, Spain) using TaqMan Universal PCR
Master Mix, No AmpErase UNG. Forty cycles at 95 °C for 15 s and 60 °C for 1 min
were performed32,55–57. Relative mRNA levels were calculated by standard for-
mulae (ΔΔCt method) using GAPDH or TBP as an endogenous control. The
results referred to a randomly selected basal sample considered as value= 1.0.
Gene-specific TaqMan probes used in this study are indicated in the Supplemen-
tary Methods.
Patients and human kidney samples. Human kidney tissue samples were
obtained from 19 patients who underwent nephrectomy due to malignancies or
hydronephrosis, and 24 patients who were submitted to renal biopsy and were
confirmed with IgA nephropathy or glomerulonephritis in the University Hospital
Arnau de Vilanova in Lleida, between 2013 and 2018. The human kidney samples
were obtained with the support of IRBLleida Biobank (B.0000682) and PLATA-
FORMA BIOBANCOS PT17/0015/0027. Two experienced pathologists evaluated
the samples for the presence of renal fibrosis.
The study involving human samples was approved by the Ethics Committee for
the Clinical Investigation of the University Hospital Arnau de Vilanova in Lleida
(CEIC-1587), and complied with all relevant ethical regulations and the guidelines
of the Declaration of Helsinki. Prior to inclusion in the study, all patients provided
an informed consent for the collection and use of their kidney tissues for research.
The informed consent specified that medical data such as age, sex and BMI could
be shared and used for research.
Animals and experimental protocol. Male C57BL/6J mice (8–12-weeks old),
weighing ~20–23 g, were purchased from Charles River (Barcelona, Spain). Mice
were housed and maintained in a barrier facility, and pathogen-free procedures
were used in all mouse rooms. Animals were kept in a 12-h-light/dark cycle at
22 °C with ad libitum access to food and water.
The male C57BL/6J mouse model of renal fibrosis was established by UUO.
Under general anesthesia (Isoflurane), male mice (8–10-weeks old) were
subjected to UUO by double-ligating the left ureter using 4-0 silk after a
lateral abdominal incision. After the surgery mice received pain medication
(buprenorphine, 0.05 mg/kg, sc). Mice were euthanized at days 5 and 15 after the
surgery. Blood was collected by cardiac puncture and the animals were perfused
with PBS through a puncture in the left ventricle. The organs of interest were
collected for histologic examination and molecular analysis. One part of the kidney
was fixed in 4% paraformaldehyde/PBS for histologic examinations after
embedding in paraffin and/or Bright Cryo-M-Bed compound (Bright Instrument
Co). The remaining kidney tissue was snap-frozen in liquid nitrogen and kept at
−80 °C for protein and mRNA extractions.
All animal studies were approved by the local Animal Ethics Committee of the
University of Lleida (CEEA 07-02/14), and complied with all relevant ethical
regulations and the guidelines of European Research Council for the Care and Use
of Laboratory Animals.
Generation of RPTEC-specific SNCA null mice. To generate RPTEC-specific
SNCA null mice, SNCAflox mice [B6(Cg)-Sncatm1.1Vlb/J; JAX stock #025636]
purchased from the Jackson Laboratory (Bar Harbor, ME)58 were bred with a
PEPCKCre+ transgenic mice (Cre recombinase under the control of the phos-
phoenolpyruvate carboxykinase promoter39) on a C57BL/6J background
(kindly provided by Dr. Volker Haase, Vanderbilt University)39 to yield
PEPCKCre+-SNCAwt/flox progeny. The PEPCKCre transgenic mice show ~10-fold
increase in PEPCK expression in renal proximal tubule59. PEPCKCre+-SNCAwt/flox
mice were intercrossed to obtain the breeders to produce the experimental geno-
types PEPCKCre+-SNCAwt/wt (control group) and PEPCKCre+-SNCAflox/flox
(proximal tubular cell-specific SNCA deletion). Mice were genotyped by tail biopsy
PCR using Cre transgene and SNCAloxP specific primers (Supplemental Material).
To assess the specificity of Cre-recombinase expression, PEPCKCre mice were
crossed with reporter mT/mG [B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato-
EGFP)Luo/J] mice obtained from the Jackson Laboratory (Bar Harbor, ME). The
mT/mG ROSA reporter mice express red fluorescence prior to, and green fluor-
escence following, Cre-mediated recombination. Male PEPCKCre+-SNCAwt/wt and
PEPCKCre+-SNCAflox/flox mice (8–10 weeks old) were used in experiments of renal
fibrosis induced by UUO.
Statistical analyses. Statistical analysis was performed using GraphPad Prism
(GrahPad Software, San Diego California USA). All data are expressed as mean ±
SEM. Differences among groups were assessed by one-way ANOVA or two-way
ANOVA, followed up by Tukey’s test, as needed. Differences between two groups
were evaluated by the Student’s t-test.
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Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Source data are provided as a Source Data file. All other data supporting the findings of
this study are included in the supplementary information or available from the
corresponding author upon reasonable request.
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